SCHEDULE: Solas Capital Management Reports Stake in MAIA Biotechnology

Solas Capital Management, LLC and Frederick Tucker Golden report beneficial ownership of 4.9% of MAIA Biotechnology, Inc. common stock.

Summary

• Solas Capital Management, LLC and Frederick Tucker Golden have filed an amendment to Schedule 13G, reporting their beneficial ownership of MAIA Biotechnology, Inc. common stock.
• The filing indicates a beneficial ownership of 3,030,845 shares, representing 4.9% of the class of securities.
• This ownership percentage is based on 60,800,758 shares of common stock outstanding as of May 11, 2026, as reported by the Issuer in its Form 10-Q.
• Solas Capital Management, LLC is identified as an investment adviser registered under the Investment Advisers Act of 1940.
• Frederick Tucker Golden is identified as the Portfolio Manager of Solas Capital Management, LLC, with investment and voting discretion.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting on beneficial ownership thresholds without significant new financial or strategic information.

Positives

• Reporting of beneficial ownership at a specific threshold (4.9%) provides transparency to the market regarding significant shareholders.
• The filing confirms the number of shares held (3,030,845) and the total outstanding shares (60,800,758) as of a recent date.

Negatives

• The filing does not contain new financial performance data or strategic updates, limiting its immediate impact on valuation.
• The disclaimer of beneficial ownership by the Funds managed by Solas Capital Management, LLC, while standard, indicates the reporting is based on discretionary power rather than direct equity.

Risks

• Potential for future changes in beneficial ownership by Solas Capital Management, LLC, which could impact share price if significant buying or selling occurs.
• The filing does not provide insight into the investment strategy or rationale behind holding this stake in MAIA Biotechnology, Inc.

Future Outlook

The filing does not contain any forward-looking statements or guidance from the company.

Management Comments

• Solas Capital Management, LLC is an investment adviser that is registered under the Investment Advisers Act of 1940.
• Mr. Frederick Tucker Golden, as Portfolio Manager of Solas Capital Management, LLC, with the power to exercise investment and voting discretion, may be deemed to be the beneficial owners of all shares of Common Stock held by the Fund and by the Other Fund.
• Pursuant to Rule 13d-4 under the Securities Exchange Act of 1934, as amended, each of the Fund and the Other Fund expressly disclaims beneficial ownership over any of the securities reported in this statement, and the filing of this statement shall not be construed as an admission that either the Fund or the Other Fund are the beneficial owner of any of the securities reported herein.
• By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors crossing certain ownership thresholds. This filing indicates Solas Capital Management, LLC's position as a significant, though not controlling, shareholder in the biotechnology sector, a field often characterized by substantial investment and potential volatility.

Stakeholder Impact

• Shareholders gain clarity on a significant beneficial owner, potentially influencing trading decisions.
• The market receives updated information on the shareholder structure of MAIA Biotechnology, Inc.

Next Steps

• Solas Capital Management, LLC and Frederick Tucker Golden will continue to monitor their beneficial ownership levels in MAIA Biotechnology, Inc.
• Future filings will be made if ownership thresholds change significantly.

Key Dates

Keywords

MAIA Biotechnology, Solas Capital Management, Schedule 13G, Beneficial Ownership, Investment Adviser, Common Stock, Shareholder